PExA develops methods for collection of biomarkers. The company provides collection and measuring instruments, consumables, and other analytical services for the examination of patients’ lungs. The products are primarily used in the treatment of airway diseases, such as asthma and chronic obstructive pulmonary disease, COPD. In addition to the main business, also service and support is offered. The company was founded in 2014 and is based in Gothenburg.

Quotes for PExA AB

Right Now

+/-
0.029
%
8,06%
Latest
0.389
High
0.389
Low
0.35
Volume
2 943
Turnover (SEK)
1 038
Market Value (MSEK)
16,4
Time (Latest trade)
2024-04-23 12:22

Board

CEO

  • Tomas Gustafsson

Chairperson of the Board

  • Claes Holmberg

Board

  • Anna-Carin Olin
  • Åsa Wheelock
  • Björn Dahlöf
  • Martin Malmström
  • Roy Jonebrant
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Pexa på Lifesciencedagen 2024

    Pexa presenterar på Mangold Insights Life Science Dag

    PExA - Utvecklar en teknologi för tidig upptäckt av biomarkörer inom lungmedicin

    PExA – Particles in Exhaled Air

    Largest Owners

    Name Capital % Votes % Date
    Nordnet Pensionsförsäkring 12,29 11,25 2024-03-26
    Sven Christer Andersson 10,47 9,59 2024-03-26
    Avanza Pension 9,76 8,94 2024-03-26
    Anna-Carin Olin 3,94 10,01 2024-03-26
    Ola Hermansson 3,79 3,98 2024-03-26
    Jan Emander 2,73 2,50 2024-03-26
    Jimmy Biesért 1,86 1,70 2024-03-26
    Mikael Blihagen 1,73 1,58 2024-03-26
    Malin Persson 1,53 1,40 2024-03-26
    Patrick Svensson 1,38 1,26 2024-03-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2024-05-15 Delårsrapport 2024-Q1

    • 2024-05-29 Årsstämma 2023

    • 2024-08-23 Delårsrapport 2024-Q2

    • 2024-11-08 Delårsrapport 2024-Q3

    • 2025-02-20 Bokslutskommuniké 2024

    Annual reports, prospectus etc.